Univariate Cox regression analysis and forest plot suggested that SLC16A3 acts as a risk factor for patients with PAAD, CESC, LUSC, LUAD, CHOL, LGG, MESO, and OSCC. Here, SLC16A3 is linked to pancreatic adenocarcinoma.